6151 - 6200 of 8620 Results
Title
Year
-
OPENTitle: Australian Parkinson’s Genetics Study (APGS): pilot (n=1532)Journal Name: BMJ OpenPublisher: BMJVol: 12Issue #: 2Start Page: e052032End Page: e052032Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/bmjopen-2021-052032Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/12/2/e052032.full.pdfCitation Count: 9
-
RESTRICTEDTitle: Serum peroxiredoxin 3 is reduced in genetic carriers of Parkinson’s diseaseJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 250End Page: 251Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2022-329433Citation Count: 3
- Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts2022OPENTitle: Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohortsJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 9Start Page: 952End Page: 959Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1136/jnnp-2021-327376Best OA location URL: https://jnnp.bmj.com/content/jnnp/93/9/952.full.pdfCitation Count: 11
- Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversion2022RESTRICTEDTitle: Serum GFAP differentiates Alzheimer’s disease from frontotemporal dementia and predicts MCI-to-dementia conversionJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 93Issue #: 6Start Page: 659End Page: 667Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2021-328547Citation Count: 75
- Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune Disorders2021OPENTitle: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune DisordersJournal Name: Current Chinese ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/2666001601666211126091737Best OA location URL: https://hal.science/hal-03806707Citation Count: 0
-
OPENTitle: QEEG abnormalities in cognitively unimpaired patients with deliriumJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 94Issue #: 3Start Page: 251End Page: 254Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1136/jnnp-2022-330010Best OA location URL: https://jnnp.bmj.com/content/jnnp/94/3/251.full.pdfCitation Count: 7
-
RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 0
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson Disease—ReplyJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21011Citation Count: 3
-
RESTRICTEDTitle: Effect of Urate-Elevating Inosine on Progression of Early Parkinson DiseaseJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 1Start Page: 85End Page: 85Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jama.2021.21008Citation Count: 2
- Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson Disease2022OPENTitle: Association of Cerebrospinal Fluid Neurofilament Heavy Protein Levels With Clinical Progression in Patients With Parkinson DiseaseJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 7Start Page: e2223821End Page: e2223821Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.23821Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2794635/wang_2022_oi_220672_1659467066.66779.pdfCitation Count: 10
- Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood Factors2022OPENTitle: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 10Start Page: e2235068End Page: e2235068Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdfCitation Count: 50
- Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK Population2022OPENTitle: Assessment of Risk Factors and Early Presentations of Parkinson Disease in Primary Care in a Diverse UK PopulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 4Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0003Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2789505/jamaneurology_simonet_2022_oi_220001_1649435706.38428.pdfCitation Count: 54
- Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer Disease2022OPENTitle: Divergent Cortical Tau Positron Emission Tomography Patterns Among Patients With Preclinical Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 6Start Page: 592End Page: 592Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.0676Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9016616Citation Count: 56
-
OPENTitle: Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 652End Page: 652Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1166Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2793004/jamaneurology_le_guen_2022_oi_220025_1656444964.82183.pdfCitation Count: 64
- Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies2021OPENTitle: Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy BodiesJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 1Start Page: 32End Page: 32Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4222Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2786605/jamaneurology_gonzalez_2021_oi_210074_1643670411.5671.pdfCitation Count: 74
-
RESTRICTEDTitle: Timing of Physical Therapy Sessions for Individuals With Parkinson Disease May Unlock BenefitsJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 12Start Page: 1219End Page: 1219Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.2649Citation Count: 5
-
OPENTitle: Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma BiomarkersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 11Start Page: 1155End Page: 1155Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.3265Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9552044Citation Count: 25
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1601Citation Count: 0
-
RESTRICTEDTitle: Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—ReplyJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 7Start Page: 726End Page: 726Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2022.1604Citation Count: 0
-
RESTRICTEDTitle: Adjunctive Therapies in Parkinson Disease—Have We Made Meaningful Progress?Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 79Issue #: 2Start Page: 119End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.4140Citation Count: 4
- Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.2022OPENTitle: Physical inactivity links depressive symptoms and cognitive functioning among individuals with Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 505End Page: 512Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000837Best OA location URL: https://doi.org/10.1037/neu0000837Citation Count: 6
- Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson’s disease.2022OPENTitle: Intraindividual variability in neuropsychological performance predicts longitudinal cortical volume loss in early Parkinson’s disease.Journal Name: NeuropsychologyPublisher: American Psychological Association (APA)Vol: 36Issue #: 6Start Page: 513End Page: 519Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1037/neu0000809Best OA location URL: http://psycnet.apa.org/journals/neu/36/6/513.pdfCitation Count: 4
- Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities2022RESTRICTEDTitle: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental DisabilitiesJournal Name: Psychiatric ServicesPublisher: American Psychiatric Association PublishingVol: 73Issue #: 12Start Page: 1389End Page: 1392Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.ps.202100524Citation Count: 14
-
OPENTitle: GPNMB confers risk for Parkinson’s disease through interaction with α-synucleinJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abk0637Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9870036Citation Count: 103
- A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversity2022OPENTitle: A NAC domain mutation (E83Q) unlocks the pathogenicity of human alpha-synuclein and recapitulates its pathological diversityJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 17Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abn0044Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0044?download=trueCitation Count: 30
-
RESTRICTEDTitle: Toward preventing Parkinson’s diseaseJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 818End Page: 819Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.add7162Best OA location URL: https://resolver.sub.uni-goettingen.de/purl?gro-2/113804Citation Count: 15
- Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencing2022OPENTitle: Comprehensive genetic diagnosis of tandem repeat expansion disorders with programmable targeted nanopore sequencingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 9Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm5386Best OA location URL: https://doi.org/10.1126/sciadv.abm5386Citation Count: 131
- Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites2022OPENTitle: Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolitesJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 378Issue #: 6618Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abm3233Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9993714Citation Count: 165
-
OPENTitle: Membrane curvature sensing and stabilization by the autophagic LC3 lipidation machineryJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 50Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.add1436Best OA location URL: https://escholarship.org/uc/item/39r5f1mnCitation Count: 36
- Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s disease2022OPENTitle: Mapping microstructural gradients of the human striatum in normal aging and Parkinson’s diseaseJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 28Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/sciadv.abm1971Best OA location URL: https://doi.org/10.1126/sciadv.abm1971Citation Count: 37
- Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse model2022OPENTitle: Astrocytic α2-Na + /K + ATPase inhibition suppresses astrocyte reactivity and reduces neurodegeneration in a tauopathy mouse modelJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 632Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abm4107Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9161722Citation Count: 64
- Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication response2022RESTRICTEDTitle: Monitoring gait at home with radio waves in Parkinson’s disease: A marker of severity, progression, and medication responseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 663Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.adc9669Citation Count: 66
-
RESTRICTEDTitle: Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 648Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.abj2658Citation Count: 163
- Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants2022OPENTitle: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein VariantsJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 13Issue #: 12Start Page: 1790End Page: 1804Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.2c00190Citation Count: 4
-
OPENTitle: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid VesiclesJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 61Issue #: 17Start Page: 1766End Page: 1773Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10289115Citation Count: 9
- Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease2022RESTRICTEDTitle: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s DiseaseJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 65Issue #: 24Start Page: 16801End Page: 16817Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605Citation Count: 16
-
OPENTitle: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 PandemicJournal Name: JAMAPublisher: American Medical Association (AMA)Vol: 327Issue #: 9Start Page: 801End Page: 801Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jama.2022.1510Best OA location URL: https://jamanetwork.com/journals/jama/articlepdf/2789055/jama_suran_2022_mn_220006_1645750114.50702.pdfCitation Count: 6
- Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart review2023OPENTitle: Frequency of and factors associated with antiseizure medication discontinuation discussions and decisions in patients with epilepsy: A multicenter retrospective chart reviewJournal Name: Epilepsia OpenPublisher: WileyVol: 8Issue #: 2Start Page: 371End Page: 385Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/epi4.12695Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/epi4.12695Citation Count: 7
-
OPENTitle: The Impact of the COVID‐19 Pandemic on Care Partners of People with Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 4Start Page: 596End Page: 605Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13678Best OA location URL: https://escholarship.org/content/qt2wb861nd/qt2wb861nd.pdfCitation Count: 1
- Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's Disease2023OPENTitle: Quantified Striatal Dopaminergic Denervation as Predictor for Motor Outcomes in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 896End Page: 902Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13726Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13726Citation Count: 1
-
OPENTitle: Predictors of Future Deep Brain Stimulation Surgery in de novo Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 6Start Page: 933End Page: 942Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13747Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10272891Citation Count: 1
- Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on Aging2021OPENTitle: Insomnia symptom subtypes and manifestations of prodromal neurodegeneration: a population-based study in the Canadian Longitudinal Study on AgingJournal Name: Journal of Clinical Sleep MedicinePublisher: American Academy of Sleep Medicine (AASM)Vol: 18Issue #: 2Start Page: 345End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5664/jcsm.9562Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8804990Citation Count: 10
- Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment2023OPENTitle: Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairmentJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00531-yBest OA location URL: https://www.nature.com/articles/s41531-023-00531-y.pdfCitation Count: 20
-
OPENTitle: Unveiling the B cell receptor structureJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 377Issue #: 6608Start Page: 819End Page: 820Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.add8065Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11044948Citation Count: 10
- Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in Osteosarcoma2022OPENTitle: Comprehensive Surfaceome Profiling to Identify and Validate Novel Cell-Surface Targets in OsteosarcomaJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 21Issue #: 6Start Page: 903End Page: 913Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1158/1535-7163.mct-21-0836Best OA location URL: https://aacrjournals.org/mct/article-pdf/21/6/903/3191485/903.pdfCitation Count: 26
- Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progression2020OPENTitle: Sequences of cognitive decline in typical Alzheimer's disease and posterior cortical atrophy estimated using a novel event‐based model of disease progressionJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 7Start Page: 965End Page: 973Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/alz.12083Best OA location URL: https://doi.org/10.1002/alz.12083Citation Count: 47
-
OPENTitle: Distinct tau PET patterns in atrophy‐defined subtypes of Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: 2Start Page: 335End Page: 344Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.jalz.2019.08.201Best OA location URL: https://escholarship.org/content/qt7k74z129/qt7k74z129.pdfCitation Count: 98
- Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's disease2020OPENTitle: Harnessing the paradoxical phenotypes of APOE ɛ2 and APOE ɛ4 to identify genetic modifiers in Alzheimer's diseaseJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 5Start Page: 831End Page: 846Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12240Best OA location URL: https://doi.org/10.1002/alz.12240Citation Count: 16
- Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiology2020OPENTitle: Long genes are more frequently affected by somatic mutations and show reduced expression in Alzheimer's disease: Implications for disease etiologyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 17Issue #: 3Start Page: 489End Page: 499Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/alz.12211Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.12211Citation Count: 28
- Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer’s disease risk in humans2020OPENTitle: Epigenomic features related to microglia are associated with attenuated effect of APOE ε4 on Alzheimer’s disease risk in humansJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 16Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/alz.043533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/alz.043533Citation Count: 6